Plasma Circulating Terminal Differentiation-Induced Non-Coding RNA Serves As a Biomarker in Breast Cancer

Overview

Journal Int J Hematol Oncol Stem Cell Res

Specialty Hematology

Date 2024 Apr 29

PMID 38680708

Authors

Zeynab Shaghaghi Torkdari

Mohammad Khalaj-Kondori

Mohammad Ali Hosseinpour Feizi

Affiliations

Soon will be listed here.

Abstract

Breast cancer is identified as the most common malignancy and cause of cancer-related death worldwide. Compared with healthy controls, this study evaluated the expression level and diagnostic power of lncRNA plasma in breast cancer patients. Fifty-eight women diagnosed with invasive ductal carcinoma and fifty healthy age- matched controls were included in the study. TRIzol LS regent was used to isolate the total RNA from the whole plasma. Total RNA was converted to cDNA using Prime Script RT reagent kit and the expression levels of were quantified by qRT-PCR. Low levels of lncRNA were observed in the plasma of breast cancer patients compared with control subjects. Plasma level was also positively correlated with the diagnostic age of breast cancer patients. A low level of plasma could discriminate breast cancer patients from healthy control subjects.

References

Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S . Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer. 2005; 106(1):35-41. DOI: 10.1002/cncr.21551. View

Kim Y, Yoo K, Goodman M . Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors. Asian Pac J Cancer Prev. 2015; 16(7):2857-70. DOI: 10.7314/apjcp.2015.16.7.2857. View

Wang X, Li S, Xiao H, Deng X . Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer. Technol Cancer Res Treat. 2020; 19:1533033820965574. PMC: 7785999. DOI: 10.1177/1533033820965574. View

Jazayeri S, Saadat S, Ramezani R, Kaviani A . Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer Epidemiol. 2015; 39(4):519-27. DOI: 10.1016/j.canep.2015.04.016. View

Fazel A, Hasanpour-Heidari S, Salamat F, Rajaie S, Kazeminezhad V, Naeimi-Tabiei M . Marked increase in breast cancer incidence in young women: A 10-year study from Northern Iran, 2004-2013. Cancer Epidemiol. 2019; 62:101573. DOI: 10.1016/j.canep.2019.101573. View

Xu T, Liu X, Xia R, Yin L, Kong R, Chen W . SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene. 2015; 34(45):5648-61. DOI: 10.1038/onc.2015.18. View

Tao S, Wang L, Zhu Z, Liu Y, Wu L, Yuan C . Adverse effects of bisphenol A on Sertoli cell blood-testis barrier in rare minnow Gobiocypris rarus. Ecotoxicol Environ Saf. 2019; 171:475-483. DOI: 10.1016/j.ecoenv.2019.01.007. View

Ghasemi T, Khalaj-Kondori M, Feizi M, Asadi P . lncRNA-miRNA-mRNA interaction network for colorectal cancer; An in silico analysis. Comput Biol Chem. 2020; 89:107370. DOI: 10.1016/j.compbiolchem.2020.107370. View

Rinn J, Chang H . Long Noncoding RNAs: Molecular Modalities to Organismal Functions. Annu Rev Biochem. 2020; 89:283-308. DOI: 10.1146/annurev-biochem-062917-012708. View

10.

Liu X, Ma J, Xu F, Li L . TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer. Biomed Pharmacother. 2018; 99:9-17. DOI: 10.1016/j.biopha.2018.01.049. View

11.

Thakur P, Seam R, Gupta M, Gupta M, Sharma M, Fotedar V . Breast cancer risk factor evaluation in a Western Himalayan state: A case-control study and comparison with the Western World. South Asian J Cancer. 2017; 6(3):106-109. PMC: 5615877. DOI: 10.4103/sajc.sajc_157_16. View

12.

Kolb T, Lichy J, Newhouse J . Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002; 225(1):165-75. DOI: 10.1148/radiol.2251011667. View

13.

Iwakiri J, Terai G, Hamada M . Computational prediction of lncRNA-mRNA interactionsby integrating tissue specificity in human transcriptome. Biol Direct. 2017; 12(1):15. PMC: 5465533. DOI: 10.1186/s13062-017-0183-4. View

14.

Taheri N, Bakhshandehnosrat S, Tabiei M, Kashani E, Rajaei S, Besharat S . Epidemiological pattern of breast cancer in Iranian women: is there an ethnic disparity?. Asian Pac J Cancer Prev. 2012; 13(9):4517-20. DOI: 10.7314/apjcp.2012.13.9.4517. View

15.

Barber M, Jack W, Dixon J . Diagnostic delay in breast cancer. Br J Surg. 2004; 91(1):49-53. DOI: 10.1002/bjs.4436. View

16.

Xu S, Kong D, Chen Q, Ping Y, Pang D . Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017; 16(1):129. PMC: 5525255. DOI: 10.1186/s12943-017-0696-6. View

17.

Agarwal G, Pradeep P, Aggarwal V, Yip C, Cheung P . Spectrum of breast cancer in Asian women. World J Surg. 2007; 31(5):1031-40. DOI: 10.1007/s00268-005-0585-9. View

18.

Chen F, Qi S, Zhang X, Wu J, Yang X, Wang R . lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma. Int J Oncol. 2019; 54(4):1183-1194. PMC: 6411352. DOI: 10.3892/ijo.2019.4707. View

19.

Han W, Kang S . Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat. 2009; 119(1):193-200. DOI: 10.1007/s10549-009-0388-z. View

20.

Kretz M, Siprashvili Z, Chu C, Webster D, Zehnder A, Qu K . Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2012; 493(7431):231-5. PMC: 3674581. DOI: 10.1038/nature11661. View